The presence of activated cytotoxic CD8+ T cells are important for initiating and mediating a successful response to CTLA-4 and PD-1/PD-L1 checkpoint blockade treatments 77-79 (Figure 5) and has been shown to be of prognostic value for tumor response in patients 80. The gene discussed is CD8A; the disease is neoplasm.